183 related articles for article (PubMed ID: 22739025)
1. IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer.
Li Y; Deuring J; Peppelenbosch MP; Kuipers EJ; de Haar C; van der Woude CJ
Carcinogenesis; 2012 Oct; 33(10):1889-96. PubMed ID: 22739025
[TBL] [Abstract][Full Text] [Related]
2. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
[TBL] [Abstract][Full Text] [Related]
3. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission.
Xu AT; Li Y; Zhao D; Shen J; Xu XT; Qiao YQ; Zhu MM; Wang TR; Cui Y; Ai LY; Ran ZH
Inflamm Bowel Dis; 2015 Feb; 21(2):241-50. PubMed ID: 25545374
[TBL] [Abstract][Full Text] [Related]
4. IL-23 selectively promotes the metastasis of colorectal carcinoma cells with impaired Socs3 expression via the STAT5 pathway.
Zhang L; Li J; Li L; Zhang J; Wang X; Yang C; Li Y; Lan F; Lin P
Carcinogenesis; 2014 Jun; 35(6):1330-40. PubMed ID: 24464786
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis.
Huang L; Hu B; Ni J; Wu J; Jiang W; Chen C; Yang L; Zeng Y; Wan R; Hu G; Wang X
J Exp Clin Cancer Res; 2016 Feb; 35():27. PubMed ID: 26847351
[TBL] [Abstract][Full Text] [Related]
6. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
[TBL] [Abstract][Full Text] [Related]
7. STAT1, STAT6 and adenosine 3',5'-cyclic monophosphate (cAMP) signaling drive SOCS3 expression in inactive ulcerative colitis.
Li Y; Deuring J; Peppelenbosch MP; Kuipers EJ; de Haar C; van der Woude CJ
Mol Med; 2012 Dec; 18(1):1412-9. PubMed ID: 23154639
[TBL] [Abstract][Full Text] [Related]
8. Qing Hua Chang Yin inhibits the LPS-induced activation of the IL-6/STAT3 signaling pathway in human intestinal Caco-2 cells.
Ke X; Hu G; Fang W; Chen J; Zhang X; Yang C; Peng J; Chen Y; Sferra TJ
Int J Mol Med; 2015 Apr; 35(4):1133-7. PubMed ID: 25633437
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of DNA methyltransferase-1 in non-neoplastic epithelium helps predict colorectal neoplasia risk in ulcerative colitis.
Fujii S; Katake Y; Tanaka H
Digestion; 2010; 82(3):179-86. PubMed ID: 20588031
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of IL6/IL6R-STAT3-SOCS3 signaling pathway in IBD-associated colorectal dysplastic lesions as compared to sporadic colorectal adenomas in non-IBD patients.
Gui X; Iacucci M; Ghosh S
Pathol Res Pract; 2020 Nov; 216(11):153211. PubMed ID: 32979687
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of mucosal suppressors of cytokine signaling 3 expression in ulcerative colitis.
Miyanaka Y; Ueno Y; Tanaka S; Yoshioka K; Hatakeyama T; Shimamoto M; Sumii M; Chayama K
World J Gastroenterol; 2007 Jun; 13(21):2939-44. PubMed ID: 17589943
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer.
Chen R; Pan S; Lai K; Lai LA; Crispin DA; Bronner MP; Brentnall TA
World J Gastroenterol; 2014 Dec; 20(45):17037-48. PubMed ID: 25493016
[TBL] [Abstract][Full Text] [Related]
13. Pien Tze Huang suppresses IL-6-inducible STAT3 activation in human colon carcinoma cells through induction of SOCS3.
Shen A; Chen Y; Hong F; Lin J; Wei L; Hong Z; Sferra TJ; Peng J
Oncol Rep; 2012 Dec; 28(6):2125-30. PubMed ID: 23027374
[TBL] [Abstract][Full Text] [Related]
14. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
[TBL] [Abstract][Full Text] [Related]
15. Elevated IL-13Ralpha2 in intestinal epithelial cells from ulcerative colitis or colorectal cancer initiates MAPK pathway.
Mandal D; Levine AD
Inflamm Bowel Dis; 2010 May; 16(5):753-64. PubMed ID: 20014020
[TBL] [Abstract][Full Text] [Related]
16. Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis.
Yu LZ; Wang HY; Yang SP; Yuan ZP; Xu FY; Sun C; Shi RH
World J Gastroenterol; 2013 May; 19(17):2638-49. PubMed ID: 23674871
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of DNA methyltransferase-mediated gene silencing, anchorage-independent growth, and migration of colon cancer cells by interleukin-6.
Foran E; Garrity-Park MM; Mureau C; Newell J; Smyrk TC; Limburg PJ; Egan LJ
Mol Cancer Res; 2010 Apr; 8(4):471-81. PubMed ID: 20354000
[TBL] [Abstract][Full Text] [Related]
18. Expression of IL-24, an activator of the JAK1/STAT3/SOCS3 cascade, is enhanced in inflammatory bowel disease.
Andoh A; Shioya M; Nishida A; Bamba S; Tsujikawa T; Kim-Mitsuyama S; Fujiyama Y
J Immunol; 2009 Jul; 183(1):687-95. PubMed ID: 19535621
[TBL] [Abstract][Full Text] [Related]
19. Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma.
Wilop S; van Gemmeren TB; Lentjes MH; van Engeland M; Herman JG; Brümmendorf TH; Jost E; Galm O
Epigenetics; 2011 Aug; 6(8):1047-52. PubMed ID: 21934357
[TBL] [Abstract][Full Text] [Related]
20. Increased suppressor of cytokine signaling-3 expression predicts mucosal relapse in ulcerative colitis.
Li Y; Nuij VJ; Baars JE; Biermann K; Kuipers EJ; Peppelenbosch MP; de Haar C; Janneke van der Woude C
Inflamm Bowel Dis; 2013 Jan; 19(1):132-40. PubMed ID: 22535619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
